2m 2m 2m 2m 2m 2m 2m
AIM IMMUNOTECH (AIM)
NYSE
$0.35-$0.03 (-8.59%)
Price as of Jun 23, 2026 7:47 PM EDT- $10.3MMarket Cap
- -95.97%1-Year Change
- BiotechnologyIndustry
AIM IMMUNOTECH (AIM)
$0.35-$0.03 (-8.59%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 88,000 -48.24% | 170,000 -15.84% | 202,000 +43.26% | 141,000 +4.44% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 88,000 -48.24% | 170,000 -15.84% | 202,000 +43.26% | 141,000 +4.44% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -3.9M -36.68% | -6.2M -43.35% | -10.9M +56.49% | -7.0M -8.89% | |
Depreciation and Amortization Expense | 173,000 -17.22% | 209,000 +5.03% | 199,000 -8.72% | 218,000 +87.93% | |
Total Operating Expenses | 11.8M -41.07% | 19.9M -37.91% | 32.1M +60.08% | 20.1M +5.75% | |
Operating Profit | -11.7M -41.01% | -19.8M -38.05% | -31.9M +60.20% | -19.9M +5.76% | |
Interest Income | 17,000 +118.28% | -93,000 -146.50% | 200,000 +111.91% | -1.7M +735.32% | |
Interest Expense | -812,000 +38.80% | -585,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -795,000 +17.26% | -678,000 -439.00% | 200,000 +111.91% | -1.7M +526.49% | |
Total Nonoperating Income and Expense | 3.2M -38.69% | 5.2M +385.69% | 1.1M +69.95% | 629,000 +838.81% | |
Income before Taxes | -11.7M -41.01% | -19.8M -38.05% | -31.9M +60.20% | -19.9M +5.76% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -17.3M -40.20% | -29.0M +48.94% | -19.4M +1.66% | |
Net Income from Continuing Operations Applicable to Common | -14.0M -19.41% | -17.3M -40.20% | -29.0M +48.94% | -19.4M +1.66% | |
Basic EPS and Net Income | -8.62 +2,680.65% | -0.31 -48.33% | -0.60 +50.00% | -0.40 0.00% | |
Diluted EPS and Net Income | -8.62 +2,680.65% | -0.31 -48.33% | -0.60 +50.00% | -0.40 0.00% | |
Basic Weighted Average Shares | 1.6M -97.11% | 56.0M +15.30% | 48.6M +1.12% | 48.0M +1.49% | |
Diluted Weighted Average Shares | 1.6M -97.11% | 56.0M +15.30% | 48.6M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.0M +75.49% | 1.7M -68.73% | 5.4M -79.90% | 27.1M -15.70% | |
Short-Term Investments | N/A N/A | N/A N/A | 7.6M +6.92% | 7.1M -57.20% | |
Cash and Cash Equivalents and Short-Term Investments | 3.0M +75.49% | 1.7M -86.99% | 13.1M -61.77% | 34.2M -29.89% | |
Total Current Assets | 3.3M -21.10% | 4.2M -71.31% | 14.6M -59.92% | 36.3M -27.67% | |
Accumulated Depreciation | 1.4M +2.72% | 1.4M +2.80% | 1.3M -35.18% | 2.0M -7.62% | |
Property and Plant and Equipment and Net | 71,000 -34.26% | 108,000 -14.96% | 127,000 -34.87% | 195,000 -95.18% | |
Total Long-Term Assets | 377,000 -66.10% | 1.1M -34.12% | 1.7M +40.43% | 1.2M -8.66% | |
Total Assets | 5.8M -32.83% | 8.6M -55.59% | 19.4M -52.13% | 40.5M -29.83% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 3.5M +53.84% | 2.3M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 6.2M -34.72% | 9.5M +10.21% | 8.7M +535.71% | 1.4M +102.23% | |
Total Long-Term Debt | 927,000 -66.98% | 2.8M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 170,000 -56.96% | 395,000 -20.20% | 495,000 -24.89% | 659,000 +488.39% | |
Total Liabilities | 15.6M +56.75% | 9.9M +8.56% | 9.1M +352.82% | 2.0M +157.32% | |
Retained Earnings | -440.8M +3.27% | -426.8M +4.23% | -409.5M +7.61% | -380.5M +5.38% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 10.2M -73.40% | 38.5M -32.37% | |
Total Shares Outstanding | 3.1M -95.32% | 65.5M +33.45% | 49.1M +2.12% | 48.1M +0.19% | |
Cash Flow | |||||
Cash from Operating Activities | -11.0M -26.40% | -14.9M -29.99% | -21.3M +32.03% | -16.1M +15.35% | |
Capital Expenditures | N/A N/A | 18,000 N/A | N/A N/A | 86,000 +109.76% | |
Cash from Investing Activities | 1.9M -60.62% | 4.7M +665.63% | -832,000 -107.57% | 11.0M +1,841.36% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.4M +61.20% | 6.4M +1,228.66% | 485,000 +506.25% | 80,000 -99.02% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -13,254.55% +13.96% | -11,630.59% -26.39% | -15,800.00% +11.82% | -14,129.79% +1.26% | |
Return on Assets | N/A N/A | -123.76% +27.92% | -96.75% +144.27% | -39.61% +26.61% | |
Return on Equity | N/A N/A | N/A N/A | -118.94% +191.60% | -40.79% +26.00% | |
Revenue Growth | -48.24% +204.49% | -15.84% -136.62% | 43.26% +873.41% | 4.44% +125.87% | |
Current Ratio | 0.53 +20.87% | 0.44 -73.97% | 1.68 -93.70% | 26.69 -64.23% | |
Cash Ratio | 0.48 +168.83% | 0.18 -71.62% | 0.63 -96.84% | 19.88 -58.32% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.77 +30.30% | 0.59 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow